- Home
- MOGU vs RDHL Comparison
MOGU vs RDHL Comparison
Compare MOGU & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- RDHL
- Stock Information
- Founded
- MOGU 2011
- RDHL 2009
- Country
- MOGU China
- RDHL Israel
- Employees
- MOGU N/A
- RDHL N/A
- Industry
- MOGU Business Services
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- RDHL Health Care
- Exchange
- MOGU Nasdaq
- RDHL Nasdaq
- Market Cap
- MOGU 16.2M
- RDHL 13.1M
- IPO Year
- MOGU 2018
- RDHL N/A
- Fundamental
- Price
- MOGU $2.17
- RDHL $8.07
- Analyst Decision
- MOGU
- RDHL
- Analyst Count
- MOGU 0
- RDHL 0
- Target Price
- MOGU N/A
- RDHL N/A
- AVG Volume (30 Days)
- MOGU 8.3K
- RDHL 26.7K
- Earning Date
- MOGU 07-09-2024
- RDHL 10-15-2024
- Dividend Yield
- MOGU N/A
- RDHL N/A
- EPS Growth
- MOGU N/A
- RDHL N/A
- EPS
- MOGU N/A
- RDHL N/A
- Revenue
- MOGU $22,206,772.00
- RDHL $3,707,000.00
- Revenue This Year
- MOGU N/A
- RDHL $224.90
- Revenue Next Year
- MOGU N/A
- RDHL $82.69
- P/E Ratio
- MOGU N/A
- RDHL N/A
- Revenue Growth
- MOGU N/A
- RDHL N/A
- 52 Week Low
- MOGU $1.62
- RDHL $6.43
- 52 Week High
- MOGU $3.58
- RDHL $82.00
- Technical
- Relative Strength Index (RSI)
- MOGU 48.13
- RDHL 40.51
- Support Level
- MOGU $2.26
- RDHL $7.95
- Resistance Level
- MOGU $2.50
- RDHL $8.50
- Average True Range (ATR)
- MOGU 0.25
- RDHL 0.59
- MACD
- MOGU 0.00
- RDHL -0.13
- Stochastic Oscillator
- MOGU 18.03
- RDHL 3.85
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.